Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/17/1996 | US5556943 Cell adhesion protein, gene coding for the same, process for preparing the same and carrier onto which the same is immobilized |
09/17/1996 | US5556941 Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds |
09/17/1996 | US5556940 Parathyroid hormone analogues for the treatment of osteoporosis |
09/17/1996 | US5556939 TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
09/17/1996 | US5556836 Use of D-glucopyranuronic acids and their derivatives for incorporation in pharmacologically active peptides and their salts |
09/17/1996 | US5556786 Anhidrotic ectodermal dysplasia gene and method of detecting same |
09/17/1996 | US5556784 Bacillus thuringiensis isolates active against lepidopteran pests |
09/17/1996 | US5556782 Transformed mammalian cells capable of expressing cecropin b |
09/17/1996 | US5556780 Nucleic acid sequences, diagnosis and treatment of cardiovascular diseases |
09/17/1996 | US5556770 Hybridoma growth, lipopolysaccharides |
09/17/1996 | US5556767 Polynucleotide encoding macrophage inflammatory protein γ |
09/17/1996 | US5556763 Patterns of transcription factors and lymphocytes |
09/17/1996 | US5556757 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their CNS carrier and uses thereof |
09/17/1996 | US5556755 Oligonucleotides and dna sequences |
09/17/1996 | US5556753 DNA encoding human α1 adrenegric receptors and uses thereof |
09/17/1996 | US5556750 Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems |
09/17/1996 | US5556747 Method for site-directed mutagenesis |
09/17/1996 | US5556744 Methods and compositions for diagnosing and treating certain HIV infected patients |
09/17/1996 | US5556621 Heat and acid resistant polypeptides or proteins as antiinflammatory agents |
09/17/1996 | US5556620 Colony stimulating factor for skin healing |
09/17/1996 | US5556609 Metal labled peptides for medical diagnosis of diseases |
09/16/1996 | CA2171509A1 Method of treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment |
09/14/1996 | CA2171600A1 Dna molecules |
09/12/1996 | WO1996027799A1 Method for the diagnosis of infections |
09/12/1996 | WO1996027677A2 Method of purification of recombinant viral vectors containing a therapeutic gene |
09/12/1996 | WO1996027676A2 Method and means for the production of gene products, novel recombinant dna vectors therefor and kits employing them |
09/12/1996 | WO1996027675A1 Jellyfish green fluorescent protein (gfp) expression in plants |
09/12/1996 | WO1996027673A1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
09/12/1996 | WO1996027672A1 Latency active herpes virus promoters and their use to treat neurological lesions |
09/12/1996 | WO1996027666A1 Novel avian cytokines and genetic sequences encoding same |
09/12/1996 | WO1996027665A2 Neuron-restrictive silencer factor proteins |
09/12/1996 | WO1996027661A1 Stabilizing solutions for proteins and peptides |
09/12/1996 | WO1996027611A1 A method for identifying a novel multidrug-resistance type |
09/12/1996 | WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
09/12/1996 | WO1996027609A1 Novel gene associated with suppression of tumor development |
09/12/1996 | WO1996027608A1 Process for producing a protein |
09/12/1996 | WO1996027605A1 Systematic evolution of ligands by exponential enrichment: chemi-selex |
09/12/1996 | WO1996027604A1 High-affinity oligonucleotide ligands to secretory phospholipase a2(spla2) |
09/12/1996 | WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders |
09/12/1996 | WO1996027392A1 Antigen presenting system and methods for activation of t-cells |
09/12/1996 | WO1996027390A1 Compositions and methods for stimulating antibody class switching |
09/12/1996 | WO1996027389A1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
09/12/1996 | WO1996027387A1 Identification of self and non-self antigens implicated in autoimmune disease |
09/12/1996 | WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
09/12/1996 | WO1996027385A1 Anti-obesity proteins |
09/12/1996 | WO1996027381A1 Immunosuppressive agents |
09/12/1996 | WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
09/12/1996 | WO1996027291A1 Bacillus thuringiensis isolates active against weevils |
09/12/1996 | WO1996021733A3 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy |
09/12/1996 | WO1996021468A3 Chemically modified interferon |
09/12/1996 | WO1996021028A3 Soluble heterodimeric t cell receptors and their antibodies |
09/12/1996 | WO1996021016A3 New staphylokinase derivatives |
09/12/1996 | WO1996020950A3 Compositions and methods for treating rheumatoid arthritis |
09/12/1996 | WO1996003502A3 Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer |
09/12/1996 | DE19515514C1 DNA encoding nucleolar-endosomal auto-antigen |
09/12/1996 | DE19508672A1 Cyclic parathyroid hormone fragments with lactam bridge |
09/12/1996 | CA2214726A1 Compositions and methods for stimulating antibody class switching |
09/12/1996 | CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
09/12/1996 | CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders |
09/12/1996 | CA2214453A1 Novel avian cytokines and genetic sequences encoding same |
09/12/1996 | CA2214283A1 Anti-obesity proteins |
09/12/1996 | CA2214278A1 Bacillus thuringiensis isolates active against weevils |
09/12/1996 | CA2214271A1 Neuron-restrictive silencer factor proteins |
09/12/1996 | CA2213846A1 Novel gene associated with suppression of tumor development |
09/12/1996 | CA2212125A1 Process for producing a protein |
09/12/1996 | CA2209665A1 Systematic evolution of ligands by exponential enrichment: chemi-selex |
09/12/1996 | CA2189738A1 Identification of self and non-self antigens implicated in autoimmune disease |
09/12/1996 | CA2189737A1 Stabilizing solutions for proteins and peptides |
09/11/1996 | EP0731170A1 Insect-resistant plants |
09/11/1996 | EP0731168A1 MSRV-1 virus and pathogenic and/or infectious agent MSRV-2 associated with rheumatoid arthritis |
09/11/1996 | EP0731167A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
09/11/1996 | EP0731166A2 Novel calcium-binding proteins |
09/11/1996 | EP0731165A2 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160 |
09/11/1996 | EP0731110A1 Methods for the production of conformationally stabilized cell adhesion peptides |
09/11/1996 | EP0731109A1 Purification of D-factor |
09/11/1996 | EP0730740A1 Kinase receptor activation assay |
09/11/1996 | EP0730661A1 Compounds with pth activity and recombinant dna vectors encoding same |
09/11/1996 | EP0730660A1 Chimeric proteins including protease nexin-1 variants |
09/11/1996 | EP0730659A1 METHOD FOR GENERATING A SUBTRACTED cDNA LIBRARY AND USES OF THE GENERATED LIBRARY |
09/11/1996 | EP0730657A1 Composition for the in vivo production of therapeutic products |
09/11/1996 | EP0730654A1 CLONING AND EXPRESSION CASSETTE, EXPRESSION VECTORS AND TRANSFORMED BACTERIA COMPRISING THE $i(R. CAPSULATUS FRUP) PROMOTER, AND APPLICATIONS |
09/11/1996 | EP0730652A1 Dna sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter |
09/11/1996 | EP0730651A1 Surface loop structural analogues of fibroblast growth factors |
09/11/1996 | EP0730650A1 Retroviral superantigens, superantigen peptides, and methods of use |
09/11/1996 | EP0730648A1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
09/11/1996 | EP0730647A1 Dna sequence coding for a bmp receptor |
09/11/1996 | EP0730646A1 PROTEIN TYROSINE KINASES NAMED Rse |
09/11/1996 | EP0730645A1 Translational enhancer dna |
09/11/1996 | EP0730644A1 Methods for screening for regulators of intracellular receptor transcription using progesterone receptor a subtype |
09/11/1996 | EP0730643A1 Transgenic animals harboring app allele having swedish mutation |
09/11/1996 | EP0730640A1 Improved cell cultivation method and medium |
09/11/1996 | EP0730608A1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
09/11/1996 | EP0730607A1 Novel integrin-binding peptides |
09/11/1996 | EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
09/11/1996 | EP0730604A1 Surface membrane proteins and their effect on immune response |
09/11/1996 | EP0730602A1 Nucleic acid analogs with a chelating functionality |
09/11/1996 | EP0730470A1 Improved interferon polymer conjugates |
09/11/1996 | EP0730469A1 Modified truncated complement system regulators |
09/11/1996 | EP0730466A1 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites |
09/11/1996 | EP0654039A4 Process for hemoglobin extraction and purification. |